World Journal of Endocrine Surgery

Register      Login

VOLUME 10 , ISSUE 2 ( May-August, 2018 ) > List of Articles


Use of DOTATATE PET/CT Scan in the Diagnosis and Staging of Thymic Atypical Carcinoid Tumor in a Patient with Secondary ACTH-dependent Cushing Syndrome: Look Twice and Cut Once

Geoffrey B Thompson, John Agzarian, Hisham Quandeel, Irina Bancos, Geoffrey B Johnson, Stephen C Scharf, Joanne Yi, Xiaotun Zhang, K Robert Shen

Keywords : DOTATATE, Mediastinal, Positron emission tomography, Thymic carcinoid.

Citation Information : Thompson GB, Agzarian J, Quandeel H, Bancos I, Johnson GB, Scharf SC, Yi J, Zhang X, Shen KR. Use of DOTATATE PET/CT Scan in the Diagnosis and Staging of Thymic Atypical Carcinoid Tumor in a Patient with Secondary ACTH-dependent Cushing Syndrome: Look Twice and Cut Once. World J Endoc Surg 2018; 10 (2):127-133.

DOI: 10.5005/jp-journals-10002-1231

License: CC BY-NC 4.0

Published Online: 01-10-2007

Copyright Statement:  Copyright © 2018; The Author(s).


Neuroendocrine thymic tumors represent the least common type of primary thymic tumor with a prevalence of 2 to 5%. We present a case of locally advanced thymic atypical carcinoid tumor diagnosed incidentally while investigating progressive Cushing syndrome. Computed tomography (CT) scan demonstrated a large 2.9 cm exophytic thyroid nodule and a 2.0 cm anterior mediastinal mass. Biopsy of the thyroid nodule demonstrated benign thyroid tissue, and octreotide scan revealed avid uptake in the right thyroid lobe with minimal uptake in the thymic tumor.68 Gallium-1,4,7,10-tetraazacyclododecane-N,N',N”N'”tetraacetic acid-D-Phe1,Tyr3-octreotate (Ga-68 DOTATATE) positron emission tomography (PET)/CT scan showed intense uptake in the thyroid gland followed by a moderate amount of activity in the anterior mediastinal mass. The patient underwent a median sternotomy and radical thymectomy with en bloc resection of the left innominate vein and primary repair of the superior vena cava (SVC). On further evaluation, the presumed thyroid nodule appeared contiguous with the thymic lesion and separate from the thyroid. Final pathology demonstrated a poorly differentiated 4.4 cm atypical carcinoid tumor with nine positive lymph nodes. On the third postoperative day, the serum cortisol level precipitously decreased to a level of 6.8 μg/dL. This case highlights the challenges surrounding the diagnosis of hormonally active thymic carcinoids and demonstrates the utility of Ga-68 DOTATATE PET scan in localizing somatostatinpositive neuroendocrine tumors and surgical planning.

PDF Share
  1. Gaur P, Leary C, Yao JC. Thymic neuroendocrine tumors: a SEER database analysis of 160 patients. Ann Surg 2010 Jun;251(6):1117-1121.
  2. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008 Jun;26(18):3063-3072.
  3. Goto K, Kodama T, Matsuno Y, Yokose T, Asamura H, Kamiya N, Shimosato Y. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 2001 Oct;14(10):985-994.
  4. Chaer R, Massad MG, Evans A, Snow NJ, Geha AS. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002 Nov;74(5):1733-1740.
  5. de Montpréville VT, Macchiarini P, Dulmet E. Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 1996 Jan;111(1):134-141.
  6. Fukai I, Masaoka A, Fujii Y, Yamakawa Y, Yokoyama T, Murase T, Eimoto T. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg 1999 Jan;67(1):208-211.
  7. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999 Oct;5(5):285-292.
  8. Jansson JO, Svensson J, Bengtsson BA, Frohman LA, Ahlman H, Wängberg B, Nilsson O, Nilsson M. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumor: in vitro responses to GHRH and GHRP-6. Clin Endocrinol (Oxf) 1998 Feb;48(2):243-250.
  9. Okada S, Ohshima K, Mori M. The Cushing syndrome induced by atrial natriuretic peptide-producing thymic carcinoid. Ann Intern Med 1994 Jul;121(1):75-76.
  10. Wick MR, Rosai J. Neuroendocrine neoplasms of the thymus. Pathol Res Pract 1988 Apr;183(2):188-199.
  11. De Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg 2002 Feb;73(2):675-681.
  12. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003 Mar;88(3):1066-1081.
  13. Filosso PL, Yao X, Ahmad U, Zhan Y, Huang J, Ruffini E, Travis W, Lucchi M, Rimner A, Antonicelli A, et al. Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases. J Thorac Cardiovasc Surg 2015 Jan;149(1):103-109.
  14. Litvak A, Pietanza MC. Bronchial and thymic carcinoid tumors. Hematol Oncol Clin North Am 2016 Feb;30(1): 83-102.
  15. Kayani I, Bomanji JB, Groves A,, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga- DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 2008 Jun;112(11):2447-2455.
  16. Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 2010 Feb;16(3):978-985.
  17. Guidoccio F, Grosso M, Maccauro M, Orsini F, Perri M, Boni G, Banti E, Grassetto G, Rubello D, Mariani G, et al. Current role of 111In-DTPA-Octreotide scintigraphy in diagnosis of thymic masses. Tumori 2011 Mar-Apr;97(2): 191-195.
  18. Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Octreoscan in patients with bronchial carcinoid tumors. Clin Endocrinol (Oxf) 2003 Dec;59(6):793-799.
  19. Strosberg JR, Berry MF, Taxellar HD. Thymic neuroendocrine (carcinoid) tumors. UpToDate 2016 Oct.
  20. Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, et al. Phase 3 trial of 177Lu-DOTATATE for midgut neuroendocrine tumors. N Engl J Med 2017 Jan;376(2):125-135.
  21. Kayani I, Conry BG, Groves AM, Win T, Dickson J, Caplin M, Bomanji JB. A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. J Nucl Med 2009 Dec;1927-1932.
  22. Reubi JC, Kvols LK, Waser B,, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990 Sep;50(18):5969-5977.
  23. Lococo F, Perotti G, Cardillo G, De Waure C, Filice A, Graziano P, Rossi G, Sgarbi G, Stefanelli A, Giordano A, Granone P. Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med 2015 Mar;40(3):e183-e189.
  24. Isidori AM, Sbardella E, Zatelli MC, Boschetti M, Vitale G, Colao A, Pivonello R; ABC Study Group. Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review. J Clin Endocrinol Metab 2015 Sep;100(9):3231-3244.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.